Compare HNI & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HNI | ELVN |
|---|---|---|
| Founded | 1944 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.6B |
| IPO Year | 1994 | 2020 |
| Metric | HNI | ELVN |
|---|---|---|
| Price | $31.09 | $37.51 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $70.00 | $43.40 |
| AVG Volume (30 Days) | ★ 700.0K | 562.9K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | ★ 3.73% | N/A |
| EPS Growth | N/A | ★ 3.17 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,839,000,000.00 | N/A |
| Revenue This Year | $117.19 | N/A |
| Revenue Next Year | $3.68 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 12.37 | N/A |
| 52 Week Low | $28.93 | $14.79 |
| 52 Week High | $53.29 | $48.53 |
| Indicator | HNI | ELVN |
|---|---|---|
| Relative Strength Index (RSI) | 39.17 | 37.04 |
| Support Level | $28.93 | $25.63 |
| Resistance Level | $47.09 | $44.09 |
| Average True Range (ATR) | 1.13 | 2.25 |
| MACD | 0.17 | -0.49 |
| Stochastic Oscillator | 54.34 | 2.90 |
HNI Corp is a provider of commercial furnishings and hearth products. Its two reportable segments are workplace furnishings and residential building products. The workplace furnishings segment includes furniture systems, seating, storage, tables, architectural products, ancillary products, and hospitality products. The residential building products segment includes various gas, wood, electric, and pellet-fueled fireplaces, inserts, stoves, facings, outdoor fire pits and fire tables, and accessories. The company's products are sold through independent dealers, distributors, eCommerce retailers, wholesalers, and retail outlets. A majority of the firm's revenue is generated from the Workplace furnishings segment. Geographically, it operates in the United States.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.